Search Awardees

Synergene Therapeutics

UEI: W8E3G5851JK4 • CAGE: 43DC1

Overview

Parent Awardee
Name
Synergene Therapeutics
Headquarters
Annapolis, MD
United States
Federal contract and grant recipient SYNERGENE THERAPEUTICS INC (UEI W8E3G5851JK4, CAGE 43DC1) is headquartered in Annapolis MD. Its primary registered NAICS is 541713 Research and Development in Nanotechnology. The corporation was founded in February 1998 and federally registered in August 2005.

Federal Award Analysis

Synergene Therapeutics federal award history

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating
Year Contracts Subcontracts Grants Subgrants


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating

Federal Registration and Certifications

Legal Name
SYNERGENE THERAPEUTICS INC
UEI
W8E3G5851JK4
CAGE Code
43DC1
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)

People

Vendor contacts at Synergene Therapeutics

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo

Contract Awards

Synergene Therapeutics prime contract awards

Grant Awards

Synergene Therapeutics direct grants

Subgrant Awards

Synergene Therapeutics subgrant awards

Teaming Partners

Disclosed awardee sub and prime contract and grant relationships

Synergene Therapeutics